New method for management of detrusor instability: transdermal scopolamine.
We report on the results of a pilot study using transdermal scopolamine in the management of detrusor instability (DI). Numerous agents have been used for the management of DI, however, many are associated with poor patient compliance and significant side effects. We have successfully used transdermal scopolamine on 3 patients with DI with good subjective and objective results.
D000368:Aged; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D010865:Pilot Projects; D012601:Scopolamine / Q000008:administration & dosage / Q000627:therapeutic use*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000503:physiopathology
D012601:Scopolamine